TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/30/24 16:38 | 5/29/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | M.d | 1,787 | 44.68 | 0 | 40 | 27 | D | ||||||||||||||||
5/30/24 16:38 | 5/29/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | S.d | -5,339 | 133.46 | 0 | -40 | -60 | 27 | D | |||||||||||||||
5/21/24 16:51 | 5/17/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | M.d | 0 | 0.00 | 0 | 4 | 19 | 27 | D | |||||||||||||||
1/5/23 18:21 | 1/3/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | M.d | 385 | 12.85 | 0 | 30 | 25 | D | ||||||||||||||||
1/5/23 18:21 | 1/3/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | S.d | -3,566 | 118.86 | 0 | -30 | -54 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |